Raymond James Financial’s Milestone Pharmaceuticals MIST Stock Holding History

Raymond James Financial’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.3K	Buy	30,070 +3,470	+13%	+$5.55K	﹤0.01%	5280
2026 Q1	$31.7K	Hold	26,600	–	–	﹤0.01%	5167
2025 Q4	$53.7K	Hold	26,600	–	–	﹤0.01%	5005
2025 Q3	$53.2K	Sell	26,600 -16,635	-38%	-$29.3K	﹤0.01%	4816
2025 Q2	$83.9K	Buy	43,235 +10,000	+30%	+$13.3K	﹤0.01%	4951
2025 Q1	$26.6K	Buy	+33,235	New	+$66.1K	﹤0.01%	4692

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Raymond James Financial's MIST Position: Q2 2026 in Review

Raymond James Financial increased its Milestone Pharmaceuticals (MIST) stake by 13% in Q2 2026, buying an estimated $5.55K and bringing the position to 30,070 shares worth $40.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5280.

Raymond James Financial first reported a position in MIST in Q1 2025 and has held it in 6 quarters since. The position peaked at $83.9K in Q2 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Raymond James Financial held 30,070 shares of Milestone Pharmaceuticals worth $40.3K as of Q2 2026.
Raymond James Financial bought 3,470 Milestone Pharmaceuticals shares in Q2 2026, an estimated $5.55K.
Milestone Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5280 holding.
Raymond James Financial first reported a position in Milestone Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Raymond James Financial's Milestone Pharmaceuticals position peaked at $83.9K in Q2 2025.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.